Literature DB >> 4855737

Inhibition of virus release by antibodies to surface antigens of influenza viruses.

W R Dowdle, J C Downie, W G Laver.   

Abstract

When influenza virus was mixed with antisera to its surface subunits before inoculation of cell cultures, anti-hemagglutinin antibodies neutralized infectivity but anti-neuraminidase did not. When the antisera were added after infection of cell cultures, anti-hemagglutinin and anti-neuraminidase antibodies were equally effective in reducing virus titers in culture fluids. Decreased virus titers were not due to interference of antibody with assay and were not accompanied by a reduction in the synthesis of hemagglutinin and neuraminidase subunits. Both antisera also effectively prevented in vitro virus spread. Inhibition of virus release by neuraminidase antibody appeared unrelated to its antienzyme property. Hydrolysis of N-acetyl neuraminic acid residues of infected host cells proceeded unimpaired in the presence of subunit antisera. Anti-hemagglutinin and anti-neuraminidase antibodies may act to prevent virus release by binding newly formed virus subunits to each other and to anti-genically altered cell membranes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4855737      PMCID: PMC355293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS.

Authors:  W G LAVER
Journal:  J Mol Biol       Date:  1964-07       Impact factor: 5.469

2.  Influenza A neuraminidase antibody assay with sensitized erythrocytes.

Authors:  J L Holston; W R Dowdle
Journal:  Appl Microbiol       Date:  1973-01

3.  Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies.

Authors:  H Brecht; U Hämmerling; R Rott
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

4.  Reactions of antibodies with surface antigens of influenza virus.

Authors:  R G Webster; W G Laver; E D Kilbourne
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

5.  Functional significance of sialidase during influenza virus multiplication: an electron microscope study.

Authors:  J T Seto; F S Chang
Journal:  J Virol       Date:  1969-07       Impact factor: 5.103

6.  Flocculation of influenza virus by specific anti-neuraminidase antibody.

Authors:  A P Kendal; C R Madeley
Journal:  Arch Gesamte Virusforsch       Date:  1970

7.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11

8.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

9.  Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus.

Authors:  R W Compans; N J Dimmock; H Meier-Ewert
Journal:  J Virol       Date:  1969-10       Impact factor: 5.103

10.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

View more
  24 in total

1.  Inhibition of bovine leukemia virus release by antiviral antibodies.

Authors:  D M Driscoll; M Onuma; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Antibodies to cell surface proteins redirect intracellular trafficking pathways.

Authors:  Christine A St Pierre; Deborah Leonard; Silvia Corvera; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  Exp Mol Pathol       Date:  2011-07-23       Impact factor: 3.362

3.  The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.

Authors:  C Orvell; K Kristensson
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.

Authors:  B Chesebro; K Wehrly; D Doig; J Nishio
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

Authors:  K McIntosh; J McQuillin; P S Gardner
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  An avian influenza virus of which infectivity is neutralized by antisera lacking hemagglutination-inhibition activity. Brief report.

Authors:  S Yoden; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Antigenic relationships among influenza virua A neuraminidase (N2) antigens by immunodiffusion and postinfection neutralization tests.

Authors:  W R Dowdle; W G Laver; J C Galphin; J C Downie
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

8.  Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.

Authors:  Jing Jin; Nathan M Liss; Dong-Hua Chen; Maofu Liao; Julie M Fox; Raeann M Shimak; Rachel H Fong; Daniel Chafets; Sonia Bakkour; Sheila Keating; Marina E Fomin; Marcus O Muench; Michael B Sherman; Benjamin J Doranz; Michael S Diamond; Graham Simmons
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

Review 9.  How B cells shape the immune response against Mycobacterium tuberculosis.

Authors:  Paul J Maglione; John Chan
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

10.  Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine.

Authors:  Steven Rockman; Lorena E Brown; Ian G Barr; Brad Gilbertson; Sue Lowther; Anatoly Kachurin; Olga Kachurina; Jessica Klippel; Jesse Bodle; Martin Pearse; Deborah Middleton
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.